Syndax Pharmaceuticals, Inc.盘中异动快速下跌5.02%

市场透视09-17

北京时间2024年09月17日01时06分，Syndax Pharmaceuticals, Inc.（SNDX.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报18.16美元/股，成交量31.2902万股，换手率0.37%，振幅5.39%。最近的财报数据显示，该股实现营业收入3.50百万美元，净利润-68.06百万美元，每股收益-0.80美元，毛利--，市盈率-5.35倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2468398823?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-09-17 01:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2468398823","market":"us","top_or_hot":-1,"title":"Syndax Pharmaceuticals, Inc.盘中异动 快速下跌5.02%","media":"市场透视","content":"<div>\n<p>北京时间2024年09月17日01时06分，Syndax Pharmaceuticals, Inc.（SNDX.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报18.16美元/股，成交量31.2902万股，换手率0.37%，振幅5.39%。最近的财报数据显示，该股实现营业收入3.50百万美元，净利润-68.06百万美元，每股收益-0.80美元，毛利--，市盈率-5.35倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917010603a1da94bd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Syndax Pharmaceuticals, Inc.盘中异动 快速下跌5.02%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSyndax Pharmaceuticals, Inc.盘中异动 快速下跌5.02%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-17 01:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917010603a1da94bd&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年09月17日01时06分，Syndax Pharmaceuticals, Inc.（SNDX.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报18.16美元/股，成交量31.2902万股，换手率0.37%，振幅5.39%。最近的财报数据显示，该股实现营业收入3.50百万美元，净利润-68.06百万美元，每股收益-0.80美元，毛利--，市盈率-5.35倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917010603a1da94bd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SNDX","symbol_name":"Syndax Pharmaceuticals, Inc. ","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917010603a1da94bd&s=b","article_id":"2468398823","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917010603a1da94bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2468398823","pubTimestamp":1726506362,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年09月17日01时06分，Syndax Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.02%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Nucana Plc、Surrozen Inc C/Wts 01/08/2031 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Nucana Plc、Dermata Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为2154.82%、1633.80%、1009.26%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nucana Plc、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为117.33%、69.69%、66.08%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SNDX":"Syndax Pharmaceuticals, Inc. ","BK4139":"生物科技"},"translate_title":"Syndax Pharmaceuticals, Inc. Drops 5.02% Quickly in Intraday Movement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SNDX":1},"content_text":"北京时间2024年09月17日01时06分，Syndax Pharmaceuticals, Inc.（SNDX.us）股票出现异动，股价大幅下跌5.02%。截至发稿，该股报18.16美元/股，成交量31.2902万股，换手率0.37%，振幅5.39%。最近的财报数据显示，该股实现营业收入3.50百万美元，净利润-68.06百万美元，每股收益-0.80美元，毛利--，市盈率-5.35倍。机构评级方面，在所有13家参与评级的机构中，92%的券商给予买入建议，8%的券商给予持有建议，无券商给予卖出建议。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Nucana Plc、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)、Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)涨幅较大，Nucana Plc、Dermata Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为2154.82%、1633.80%、1009.26%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、Nucana Plc、Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)，振幅分别为117.33%、69.69%、66.08%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。该公司的候选产品是对癌细胞和免疫调节细胞具有直接作用的恩替司他，以及SNDX-6352和SNDX-6352, 这是一种抗CSF-1R单克隆抗体，用于增强人体对免疫疗法已显示出耐药性的肿瘤的免疫反应。本集团的业务活动主要在美国地区开展。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468398823"}

Syndax Pharmaceuticals, Inc.盘中异动 快速下跌5.02%

精彩评论

Syndax Pharmaceuticals, Inc.盘中异动快速下跌5.02%